Article
A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk.
Breast cancer research and treatment - 1 Feb 2009
He Chunyan, Tamimi Rulla M, Hankinson Susan E, Hunter David J, Han Jiali
Abstract excerpt
Oxidative stress may be involved in breast carcinogenesis. Myeloperoxidase (MPO) is an endogenous oxidant enzyme that generates reactive oxygen species (ROS). A single nucleotide polymorphism (SNP) G-463A in the promoter region has been associated with a decrease in risk of breast cancer. We assessed the association between this polymorphism and breast cancer risk in a nested case-control study within the Nurses'...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
